2024
DOI: 10.1016/j.ijpharm.2024.124775
|View full text |Cite
|
Sign up to set email alerts
|

Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK/NF-κB and COX-2/PGE-2 pathways: Evidence from the biochemical, histological, and metabolomic analysis

Zeinab A. El-Gendy,
Naglaa M. Ammar,
Abdulsalam M. Kassem
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 87 publications
0
0
0
Order By: Relevance